Rising medication deficiencies in the U.S. led to an expanded interest in new medications as most would consider it normal to drive development of the U.S. 503B compounding pharmacies market during the figure time frame. As indicated by the American Society of Health-System Pharmacists (ASHP) in 2020, huge deficiencies in tranquilizers, immobile people, and analgesics were seen by clinics, of which a large part of the new deficiencies were for injectable.
Expanding item dispatches and endorsements are supposed to drive the development of the U.S. 503B compounding pharmacies market. In January 2020, Fagron Compounding Pharmacies launched their prepared-to-utilize OR needles for hydromorphone. All OR Syringes are plainly named while sticking to the American Society for Testing and Materials (ASTM), Drug Quality and Security Act (DQSA), and Institute for Safe Medication Practices’ (ISMP) medicine and sedation naming norms.
Request Here For The Sample Copy Of The Report @
https://www.coherentmarketinsights.com/insight/request-sample/4481
Market players are occupied with advertising methodologies such as coordinated efforts, consolidations, acquisitions, and development of organizations, which are supposed to drive the development of the U.S. 503B compounding pharmacies market. In 2017, Edge Pharma extended its assembling office in New York, U.S. The organization contributed around US$ 1.5 million for the development of the creation office. Besides, in 2016, Empower Pharmacy initiated another 15,000 square foot office. The new office meets Good Manufacturing Practices (cGMP) requirements and includes a 24 square foot GMP lyophilizer, a 200 square foot ISO-5 suite, and a 300 square foot USP 800-consistent risky medication cleanroom.
Effect of the Coronavirus (COVID-19) Pandemic
The coronavirus flare-up was first covered on December 31, 2019 in Wuhan, China. As per the Coronavirus (COVID-19) Weekly Epidemiological Update by the World Health Organization, approximately 169 million cases and 3.5 million deaths due to the Coronavirus (COVID-19) were accounted for up to May 30, 2021 across the globe.
The COVID-19 pandemic has impacted a few business sectors across the globe and is likewise expected to hamper the interest and supply in the U.S. 503B compounding pharmacies market. The COVID-19 pandemic has impacted the interest and supply of the U.S. 503B compounding pharmacies market in three fundamental ways; by straightforwardly influencing the creation and request; by making disturbances in dissemination channels; and by its monetary effect on firms and monetary business sectors.
Request PDF Brochure with Latest Insights @
https://www.coherentmarketinsights.com/insight/request-pdf/4481
Besides, advertising techniques, organizations further the development of the U.S. 503B compounding pharmacies market. In August 2019, Nephron Pharmaceuticals Corporation announced its association with Clemson University, South Carolina, U.S. to make a mechanical answer for mechanized needle filling, which will assist with improving sterile assembly in the drug creation cycle and help in dealing with the developing clinic requests. This assisted the organization with giving clean, pre-filled meds to combat drug deficiencies in emergency clinics and clinical offices across the U.S.
Key Takeaways
The U.S. 503B compounding pharmacies market is estimated to be valued at US$ 919 million in 2021 and is supposed to increase to US$ 1,508.1 million by 2028, seeing a CAGR of 7.3% during the estimated timeframe, inferable from the rising number of item dispatches and endorsements. In 2019, Fagron Sterile Services U.S. extended its controlled substances item portfolio by sending off ketamine injectable.
Key companies contributing to the U.S. 503B compounding pharmacies market include Avella Specialty Pharmacy, Empower Pharmacy, Athenex, Inc., ASP Cares, Olympia Pharmacy, QuVa Pharma, Nephron Pharmaceuticals Corporation, Central Admixture Pharmacy Services, Inc., US Compounding Inc., Wells Pharma of Houston, LLC, IntegraDose Compounding Services, LLC, Imprimis NJOF, LLC, Fagron Compounding Pharmacies, Edge Pharma, Carie Boyd’s Prescription Shop, and Atlas Pharmaceuticals.
Reasons to buy this U.S. 503B Compounding Pharmacies Market Report
◘ Save time carrying out entry-level research by identifying the size, growth, and leading players in the emerging U.S. 503B Compounding Pharmacies Market
◘ Use the Five Forces analysis to determine the competitive intensity and therefore attractiveness of the emerging U.S. 503B Compounding Pharmacies Market
◘ Leading company profiles reveal details of key U.S. 503B Compounding Pharmacies Market players emerging five operations and financial performance
◘ Add weight to presentations and pitches by understanding the future growth prospects of the emerging U.S. 503B Compounding Pharmacies Market with five year historical forecasts
◘ Compares data from North America, South America, Asia Pacific Europe and Middle East Africa, alongside individual chapters on each region
The next part also sheds light on the gap between supply and consumption. Apart from the mentioned information, growth rate of U.S. 503B Compounding Pharmacies Market in 2028 is also explained. Additionally, type wise and application wise consumption tables and figures of U.S. 503B Compounding Pharmacies Market are also given.
𝐁𝐮𝐲 𝐓𝐡𝐢𝐬 𝐂𝐨𝐦𝐩𝐥𝐞𝐭𝐞 𝐁𝐮𝐬𝐢𝐧𝐞𝐬𝐬 𝐑𝐞𝐩𝐨𝐫𝐭 𝐖𝐢𝐭𝐡 𝐅𝐥𝐚𝐭 𝐔𝐒𝐃 𝟐𝟎𝟎𝟎 𝐎𝐟𝐟 @
https://www.coherentmarketinsights.com/promo/buynow/4481
Table of Content
- Research Objectives and Assumptions
- Research Objectives
- Assumptions
- Abbreviations
- Market Purview
- Report Description
- Market Definition and Scope
- Executive Summary
- Market Snippet, By Molecule
- Market Snippet, By Packaging
- Coherent Opportunity Map (COM)
- Report Description
- Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
- Drivers
- Restraints
- Market Opportunities
- Impact Analysis
- Pipeline Analysis
- PEST Analysis
- Regulatory Scenario
- Market Trends
- Key Highlights
- Mergers & Acquisitions
- Market Dynamics
- U.S 503B Compounding Pharmacies Market – Impact of Coronavirus (Covid-19) Pandemic
- Economic Impact
- Impact on Clinical Trials
- Government Initiatives
- U.S 503B Compounding Pharmacies Market, By Molecule, 2017 – 2030, (US$ Mn)
- Introduction
- Market Share Analysis, 2022 and 2030 (%)
- Y-o-Y Growth Analysis, 2018 – 2030
- Segment Trends
- Acetaminophen
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 – 2030, (US$ Mn)
- Phenylephrine
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 – 2030, (US$ Mn)
- Midazolam
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 – 2030, (US$ Mn)
- Esmolol
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 – 2030, (US$ Mn)
- Vancomycin
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 – 2030, (US$ Mn)
- Epinephrine
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 – 2030, (US$ Mn)
- Adenocaine
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 – 2030, (US$ Mn)
- Fentanyl/ Bupivacaine
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 – 2030, (US$ Mn)
- Morphine
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 – 2030, (US$ Mn)
- Amiodarone
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 – 2030, (US$ Mn)
- Heparin
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 – 2030, (US$ Mn)
- Ketamine
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 – 2030, (US$ Mn)
- Dextrose
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 – 2030, (US$ Mn)
- Hydromorphone
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 – 2030, (US$ Mn)
- Bupivacaine
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 – 2030, (US$ Mn)
- Lidocaine
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 – 2030, (US$ Mn)
- BKK (Bupivacaine, ketorolac, Ketamine)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 – 2030, (US$ Mn)
- RCK (Ropivacaine, Clonidine, Ketorolac)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 – 2030, (US$ Mn)
- RKK (Ropivacaine, Ketorolac, Ketamine)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 – 2030, (US$ Mn)
- Other Molecules
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 – 2030, (US$ Mn)
- Introduction
- U.S. 503B Compounding Pharmacies Market, By Packaging, 2017 – 2030, (US$ Mn)
- Introduction
- Market Share Analysis, 2022 and 2030 (%)
- Y-o-Y Growth Analysis, 2018 – 2030
- Segment Trends
- Vials
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 – 2030, (US$ Mn)
- Prefilled Syringes
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 – 2030, (US$ Mn)
- Ampoules
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 – 2030, (US$ Mn)
- Syringes
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 – 2030, (US$ Mn)
- Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 – 2030, (US$ Mn)
- Introduction
- Competitive Landscape
- Heat Map Analysis
- Market Share Analysis
- Central Admixture Pharmacy Services, Inc.
- Company Overview
- Product Portfolio
- Financial Overview
- Key Highlights
- Market Strategies
- Nephron Pharmaceuticals Corporation
- Company Overview
- Product Portfolio
- Financial Overview
- Key Highlights
- Market Strategies
- QuVa Pharma
- Company Overview
- Product Portfolio
- Financial Overview
- Key Highlights
- Market Strategies
- Olympia Pharmacy
- Company Overview
- Product Portfolio
- Financial Overview
- Key Highlights
- Market Strategies
- ASP Cares
- Company Overview
- Product Portfolio
- Financial Overview
- Key Highlights
- Market Strategies
- Fagron Compounding Pharmacies
- Company Overview
- Product Portfolio
- Financial Overview
- Key Highlights
- Market Strategies
- Athenex, Inc.
- Company Overview
- Product Portfolio
- Financial Overview
- Key Highlights
- Market Strategies
- Avella Specialty Pharmacy
- Company Overview
- Product Portfolio
- Financial Overview
- Key Highlights
- Market Strategies
- Atlas Pharmaceuticals
- Company Overview
- Product Portfolio
- Financial Overview
- Key Highlights
- Market Strategies
- Empower Pharmacy
- Company Overview
- Product Portfolio
- Financial Overview
- Key Highlights
- Market Strategies
- Carie Boyd’S Prescription Shop
- Company Overview
- Product Portfolio
- Financial Overview
- Key Highlights
- Market Strategies
- Edge Pharma
- Company Overview
- Product Portfolio
- Financial Overview
- Key Highlights
- Market Strategies
- Imprimis NJOF, LLC
- Company Overview
- Product Portfolio
- Financial Overview
- Key Highlights
- Market Strategies
- IntegraDose Compounding services, LLC
- Company Overview
- Product Portfolio
- Financial Overview
- Key Highlights
- Market Strategies
- Wells Pharma of Houston, LLC
- Company Overview
- Product Portfolio
- Financial Overview
- Key Highlights
- Market Strategies
- US Compounding Inc.
- Company Overview
- Product Portfolio
- Financial Overview
- Key Highlights
- Market Strategies
- SCA Pharma
- Company Overview
- Product Portfolio
- Financial Overview
- Key Highlights
- Market Strategies
- Central Admixture Pharmacy Services, Inc.
- Analyst Views
- Section
- References
- Research Methodology
- About us and Sales Contact
About Coherent Market Insights
Coherent Market Insights is a global market intelligence and consulting organization that provides syndicated research reports, customized research reports, and consulting services. We are known for our actionable insights and authentic reports in various domains including aerospace and defense, agriculture, food and beverages, automotive, chemicals and materials, and virtually all domains and an exhaustive list of sub-domains under the sun. We create value for clients through our highly reliable and accurate reports. We are also committed in playing a leading role in offering insights in various sectors post-COVID-19 and continue to deliver measurable, sustainable results for our clients.
Contact:
Coherent Market Insights
1001 4th Ave, #3200 Seattle, WA 98154, U.S.
Email: sales@coherentmarketinsights.com
United States of America: +1-206-701-6702
United Kingdom: +44-020-8133-4027
Japan: +050-5539-1737
India: +91-848-285-0837